Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinggan Jiangya Jiaonang in Primary Hypertension (Phase IV)
CTR20171358Phase 4Active
- Sponsor
- Beijing Hongtianli Pharmaceutical
- Start
- Nov 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of qinggan jiangya in essential hypertension, sponsored by Beijing Hongtianli Pharmaceutical. Started Nov 2017; status: active.
02
Drugs
qinggan jiangya
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20171358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171358.